Identifying new markers to predict gestational diabetes and large babies.
Official title: New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.
Run by University Hospital, Bordeaux · NCT06048510 · Data updated 2026-11-12
This study is testing new ways to predict gestational diabetes and large babies in pregnant women by looking at specific markers in their blood to see if they work better than the usual tests.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | December 18, 2023 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT06048510 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women aged 18 years and older, with a singleton pregnancy and less than 28 weeks of gestation.
✕Probably not a fit
Patients who have known diabetes prior to pregnancy or are beyond 28 weeks of gestation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate new glycation markers, specifically skin autofluorescence and glycated albumin, as predictors of gestational diabetes mellitus (GDM) and macrosomia in pregnant women. It compares these novel markers to the traditional HbA1c measurement to determine their effectiveness in identifying risks for adverse pregnancy outcomes. The study will involve pregnant women who are less than 28 weeks into their pregnancy and will assess their glycation levels to improve screening strategies for GDM. The goal is to enhance early detection and management of these conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved screening methods for gestational diabetes and better outcomes for mothers and infants.
How similar studies have gone: While the use of glycation markers in this context is innovative, similar studies have shown promise in identifying risks associated with gestational diabetes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Age ≥ 18 years 2. Singleton pregnancy (or twin pregnancy reduced spontaneously or medically before 14 weeks of amenorrhea) 3. Gestational age at inclusion \<28 weeks of amenorrhea 4. Participant affiliated with or beneficiary of a social security scheme 5. Collection of patient consent. Exclusion criteria: 1. Gestational age at inclusion ≥ 28 weeks of amenorrhea 2. Multiple pregnancy 3. Known diabetes prior to pregnancy 4. History of bariatric surgery 5. Expected delivery in another maternity unit not participating in the study 6. Person deprived of liberty by judicial or administrative decision 7. Guardianship or curatorship 8. Participant not affiliated or not benefiting from a social security scheme.
Where it's running
-
Hopital Pellegrin
Bordeaux, France Recruiting
Study contacts
- Study coordinator: FOUSSARD NINON, Dr
- Email: ninon.foussard@u-bordeaux.fr
- Phone: 5.57.65.60.78
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Behavioral toolkit to help pregnant women manage gestational diabetes and pregnancy-related high blood pressure.
This program will test whether a structured behavioral toolkit helps pregnant women with both gestational diabetes and pregnancy-induced high blood pressure better control their blood sugar and blood pressure.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Using a 24-hour continuous glucose monitor after delivery to predict future Type 2 diabetes risk in people with gestational diabetes
This pilot tests whether wearing a continuous glucose monitor for 24 hours immediately after delivery can help predict later Type 2 diabetes risk in people who had gestational diabetes.
-
Continuous glucose monitoring to find and manage early high blood sugar in pregnancy
This uses continuous glucose monitors in early pregnancy for people without diabetes to find and treat high blood sugar and try to reduce problems for mother and baby.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.